Twitter smoking cessation program helps smokers quit
the ONA take:
According to findings published recently in the Journal of Medical Internet Research, researchers from University of California, Irvine in Irvine, California, and Stanford University in Stanford, California, have found that when participants of a smoking cessation program tweet each other regularly on Twitter, they are more successful at stopping smoking.
For the program, called Tweet2Quit, participants communicated online via Twitter for 100 days, received a free supply of nicotine patched, and received daily automated text messages from trained counselors.
Participants were also encouraged to use an internet-based guide to develop a smoking cessation plan and to tweet their 20-person groups at least once daily about their progress.
Researchers found that 78% of two consecutive 20-person Tweet2Quit group tweeted their fellow study subjects at least once daily during the 100 days.
Results showed that the first group had a 42% smoking cessation rate compared with 75% in the second group, which benefited from changes to the automessaging process.
The findings suggest that incorporating social media-delivered automessages from trained counselors in as effective approach in promoting smoking cessation by encouraging participants to tweet about their progress, thereby holding themselves more accountable for quitting.
When participants of a smoking cessation program tweet each other regularly on Twitter, they are more successful at stopping smoking.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|